Val⁸-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid β peptide in rats (Q45803529)

16 December 2017

title

Val⁸-GLP-1 remodels synaptic activity and intracellular calcium homeostasis impaired by amyloid β peptide in rats (English)

1 reference

16 December 2017

author

Christian Hölscher

3

1 reference

16 December 2017

author name string

Xiao-Hui Wang

1

1 reference

16 December 2017

Wei Yang

2

1 reference

16 December 2017

Zhao-Jun Wang

4

1 reference

16 December 2017

Hong-Yan Cai

5

1 reference

16 December 2017

Qing-Shan Li

6

1 reference

16 December 2017

Jin-Shun Qi

7

1 reference

16 December 2017

publication date

18 January 2013

1 reference

16 December 2017

Journal of Neuroscience Research

published in

1 reference

16 December 2017

volume

91

1 reference

16 December 2017

issue

4

1 reference

16 December 2017

page(s)

568-577

1 reference

16 December 2017

The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's Disease

cites work

1 reference

Quantal currents at single-site central synapses

21 January 2018

1 reference

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

21 January 2018

1 reference

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

21 January 2018

1 reference

Ionic effects of the Alzheimer's disease beta-amyloid precursor protein and its metabolic fragments

21 January 2018

1 reference

Bis(7)-tacrine attenuates beta amyloid-induced neuronal apoptosis by regulating L-type calcium channels.

21 January 2018

1 reference

Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice

21 January 2018

1 reference

Secreted forms of beta-amyloid precursor protein protect hippocampal neurons against amyloid beta-peptide-induced oxidative injury.

21 January 2018

1 reference

Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

21 January 2018

1 reference

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

21 January 2018

1 reference

Receptors for the incretin glucagon-like peptide-1 are expressed on neurons in the central nervous system.

21 January 2018

1 reference

Amyloid, the presenilins and Alzheimer's disease

21 January 2018

1 reference

New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease?

21 January 2018

1 reference

cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic beta-cells. A Ca2+ signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37)

21 January 2018

1 reference

Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis

21 January 2018

1 reference

beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons.

21 January 2018

1 reference

Synaptic targeting by Alzheimer's-related amyloid beta oligomers.

21 January 2018

1 reference

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

21 January 2018

1 reference

Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease

21 January 2018

1 reference

GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.

21 January 2018

1 reference

Glutamate-induced long-term potentiation of the frequency of miniature synaptic currents in cultured hippocampal neurons

21 January 2018

1 reference

Amyloid plaque core protein in Alzheimer disease and Down syndrome

21 January 2018

1 reference

The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer's disease.

21 January 2018

1 reference

Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

Selective release of glutamine and glutamic acid produced by perfusion of GLP-1 (7-36) amide in the basal ganglia of the conscious rat

21 January 2018

1 reference

Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents.

21 January 2018

1 reference

Glucagon-like peptide-1 modulates neuronal activity in the rat's hippocampus.

21 January 2018

1 reference

Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease.

21 January 2018

1 reference

Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4.

21 January 2018

1 reference

Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.

21 January 2018

1 reference

Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis

21 January 2018

1 reference

Dendritic spines shaped by synaptic activity

21 January 2018

1 reference

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

21 January 2018

1 reference

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

21 January 2018

1 reference

Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury

21 January 2018

1 reference

Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.23181

1 reference

16 December 2017

PubMed ID

23335292

1 reference

16 December 2017